BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kitami N, Komada T, Ishii H, Shimizu H, Adachi H, Yamaguchi Y, Kitamura T, Oide H, Miyazaki A, Ishikawa M. Immunological study of anti-M2 in antimitochondrial antibody-negative primary biliary cirrhosis. Intern Med. 1995;34:496-501. [PMID: 7549131 DOI: 10.2169/internalmedicine.34.496] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Heathcote J. Primary biliary cirrhosis with features of autoimmune hepatitis. Curr Gastroenterol Rep 2001;3:60-4. [DOI: 10.1007/s11894-001-0042-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
2 Heathcote J. Autoimmune cholangitis. Gut. 1997;40:440-442. [PMID: 9176067 DOI: 10.1136/gut.40.4.440] [Cited by in Crossref: 48] [Cited by in F6Publishing: 38] [Article Influence: 1.9] [Reference Citation Analysis]
3 Omagari K, Hazama H, Kohno S. Enzyme inhibition assay for pyruvate dehydrogenase complex: Clinical utility for the diagnosis of primary biliary cirrhosis. World J Gastroenterol 2005; 11(43): 6735-6739 [PMID: 16425376 DOI: 10.3748/wjg.v11.i43.6735] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
4 Nezu S, Tanaka A, Yasui H, Imamura M, Nakajima H, Ishida H, Takahashi S. Presence of antimitochondrial autoantibodies in patients with autoimmune hepatitis. J Gastroenterol Hepatol 2006;0:060606032707024-???. [DOI: 10.1111/j.1440-1746.2006.04434.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 21] [Article Influence: 0.3] [Reference Citation Analysis]
5 Kim J, Kim B, Kim Y, Park J, Jung YH, Lee BO, Han YS, Dong SH, Kim HJ, Chang Y, Lee JI, Chang R. Autoimmune cholangitis in a patient with thymoma. J Gastroenterol Hepatol 2004;19:1324-7. [DOI: 10.1111/j.1440-1746.2002.03239.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
6 Heathcote EJ. Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines. Hepatology. 2000;31:1005-1013. [PMID: 10733559 DOI: 10.1053/he.2000.5984] [Cited by in Crossref: 290] [Cited by in F6Publishing: 249] [Article Influence: 13.2] [Reference Citation Analysis]
7 Mendes F, Lindor KD. Antimitochondrial antibody-negative primary biliary cirrhosis. Gastroenterol Clin North Am. 2008;37:479-484, viii. [PMID: 18499032 DOI: 10.1016/j.gtc.2008.02.006] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
8 Angulo P, Lindor KD. Management of Primary Biliary Cirrhosis and Autoimmune Cholangitis. Clinics in Liver Disease 1998;2:333-51. [DOI: 10.1016/s1089-3261(05)70011-8] [Cited by in Crossref: 9] [Article Influence: 0.4] [Reference Citation Analysis]
9 Bogdanos DP, Baum H, Vergani D. Antimitochondrial and other autoantibodies. Clin Liver Dis. 2003;7:759-777. [PMID: 14594130 DOI: 10.1016/s1089-3261(03)00104-1] [Cited by in Crossref: 71] [Cited by in F6Publishing: 28] [Article Influence: 3.9] [Reference Citation Analysis]
10 Mayo MJ, Lipsky PE, Miller SN, Stastny P, Combes B. Similar T-cell oligoclonality in antimitochondrial antibody-positive and -negative primary biliary cirrhosis. Dig Dis Sci. 2001;46:345-351. [PMID: 11281184 DOI: 10.1023/A: 1005609100900] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Sakauchi F, Oura A, Ohnishi H, Mori M. Comparison of the clinical features of Japanese patients with primary biliary cirrhosis in 1999 and 2004: utilization of clinical data when patients applied to receive public financial aid. J Epidemiol. 2007;17:210-214. [PMID: 18094520 DOI: 10.2188/jea.17.210] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
12 Heathcote J. Variant syndromes of autoimmune hepatitis. Clinics in Liver Disease 2002;6:669-84. [DOI: 10.1016/s1089-3261(02)00031-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
13 Liu H, Norman GL, Shums Z, Worman HJ, Krawitt EL, Bizzaro N, Vergani D, Bogdanos DP, Dalekos GN, Milkiewicz P. PBC screen: an IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis. J Autoimmun. 2010;35:436-442. [PMID: 20932720 DOI: 10.1016/j.jaut.2010.09.005] [Cited by in Crossref: 93] [Cited by in F6Publishing: 85] [Article Influence: 7.8] [Reference Citation Analysis]
14 Jiang XH, Zhong RQ, Fan XY, Hu Y, An F, Sun JW, Kong XT. Characterization of M2 antibodies in asymptomatic Chinese population. World J Gastroenterol 2003; 9(9): 2128-2131 [PMID: 12970922 DOI: 10.3748/wjg.v9.i9.2128] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
15 Mayo MJ, Lipsky PE, Miller SN, Stastny P, Combes B. Similar T-cell oligoclonality in antimitochondrial antibody-positive and -negative primary biliary cirrhosis. Dig Dis Sci. 2001;46:345-351. [PMID: 11281184 DOI: 10.1023/a:1005609100900] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
16 Neuberger J, Thomson R. PBC and AMA--what is the connection? Hepatology. 1999;29:271-276. [PMID: 9862877 DOI: 10.1002/hep.510290126] [Cited by in Crossref: 55] [Cited by in F6Publishing: 54] [Article Influence: 2.4] [Reference Citation Analysis]
17 Vierling JM. Primary biliary cirrhosis and autoimmune cholangiopathy. Clin Liver Dis. 2004;8:177-194. [PMID: 15062200 DOI: 10.1016/s1089-3261(03)00132-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
18 Vergani D, Bogdanos D. Positive markers in AMA-negative PBC. Am J Gastroenterology 2003;98:241-3. [DOI: 10.1111/j.1572-0241.2003.07270.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 2.3] [Reference Citation Analysis]
19 Feng L, Dong K, Zhang X, Ma B, Chen L, Yang Q, Chen Q, Wen X, Jin Q. Clinical significance of IgG antimitochondrial M2 antibody levels in primary biliary cholangitis: A single center study from China. PLoS One 2020;15:e0242164. [PMID: 33180817 DOI: 10.1371/journal.pone.0242164] [Reference Citation Analysis]
20 John BV, Dahman B, Deng Y, Khakoo NS, Taddei TH, Kaplan DE, Levy C. Rates of decompensation, hepatocellular carcinoma and mortality in AMA-negative primary biliary cholangitis cirrhosis. Liver Int 2021. [PMID: 34614294 DOI: 10.1111/liv.15079] [Reference Citation Analysis]
21 Vierling JM. AUTOIMMUNE CHOLANGIOPATHY. Clinics in Liver Disease 1999;3:571-84. [DOI: 10.1016/s1089-3261(05)70085-4] [Cited by in Crossref: 6] [Article Influence: 0.3] [Reference Citation Analysis]
22 Sakauchi F, Mori M, Zeniya M, Toda G. Antimitochondrial antibody negative primary biliary cirrhosis in Japan: utilization of clinical data when patients applied to receive public financial aid. J Epidemiol. 2006;16:30-34. [PMID: 16369106 DOI: 10.2188/jea.16.30] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
23 Jiang XH, Zhong RQ, Yu SQ, Hu Y, Li WW, Kong XT. Construction and expression of a humanized M2 autoantigen trimer and its application in the diagnosis of primary biliary cirrhosis. World J Gastroenterol 2003; 9(6): 1352-1355 [PMID: 12800255 DOI: 10.3748/wjg.v9.i6.1352] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
24 Miyakawa H, Abe K, Kitazawa E, Kikuchi K, Fujikawa H, Matsushita M, Kawaguchi N, Kako M. Detection of anti-branched chain 2-oxo acid dehydrogenase complex (BCOADC)-E2 antibody in primary biliary cirrhosis by ELISA using recombinant fusion protein. Autoimmunity 1999;30:11-20. [PMID: 10433090 DOI: 10.3109/08916939908994755] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
25 Zandanell S, Strasser M, Feldman A, Strebinger G, Aigner G, Niederseer D, Laimer M, Mussnig B, Paulweber B, Datz C, Aigner E. Similar clinical outcome of AMA immunoblot-M2-negative compared to immunoblot-positive subjects over six years of follow-up. Postgrad Med 2021;133:291-8. [PMID: 33538618 DOI: 10.1080/00325481.2021.1885945] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Kadokawa Y, Omagari K, Hazama H, Ohba K, Masuda J, Kinoshita H, Hayashida K, Isomoto H, Mizuta Y, Murase K. Evaluation of newly developed ELISA using "MESACUP-2 test mitochondrial M2" kit for the diagnosis of primary biliary cirrhosis. Clin Biochem. 2003;36:203-210. [PMID: 12726929 DOI: 10.1016/s0009-9120(02)00439-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]